Studying genetic changes in lymphatic leukemia
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at a genetic change called SF3B1 mutation in people with acute or chronic lymphocytic leukemia. It aims to understand how this mutation affects the disease and may help guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have acute lymphocytic leukemia or chronic lymphocytic leukemia.
- You can be any age and either gender.
- You must not have any other type of cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is examining levels of a protein called LEF1 in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Researchers want to see if LEF1 can help predict survival and confirm diagnosis.
This study looks for a specific gene change (Notch 1 mutation) in people with chronic lymphocytic leukemia (CLL) or non-Hodgkin's lymphoma (NHL). It may help doctors understand how these diseases behave and guide future treatment choices.
This study uses whole genome sequencing to analyze your leukemia's DNA. The goal is to find unique genetic changes that may help guide future treatments, though this study does not recommend any specific therapy.
This trial looks at people with acute myeloid leukemia (AML) who have a change in a gene called FLT3. It aims to understand how this change affects the disease and how well treatments work.
This study is for adults with B-cell acute lymphoblastic leukemia (ALL) that does not have three specific gene changes (called BCR-ABL1, TCF3-PBX1, and MLL-AF4). The study will look at people who are newly diagnosed or who have had their cancer come back.
This study looks at how follicular lymphoma cells change (“clonal evolution”) over time. It may help doctors understand disease behavior and guide better future treatments, especially when people may need treatment soon.
Hear when a new Acute Lymphoblastic Leukemia ALL trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.